Targeting Telomere Integrity Enhances Radiosensitivity and Reveals Adaptive DNA Damage Response Vulnerabilities in Diffuse Midline Glioma

Diffuse midline glioma (DMG), including diffuse intrinsic pontine glioma (DIPG), remains one of the most lethal pediatric malignancies, with limited durable benefit from radiotherapy (RT) due in part to adaptive DNA damage response (DDR) mechanisms. Here, we investigated whether targeting telomere integrity with the telomerase substrate analogue 6-thio-2′-deoxyguanosine (6-thio-dG; THIO) could induce therapeutically exploitable DNA damage in patient-derived DIPG models. THIO selectively suppressed DIPG cell proliferation while sparing telomerase-negative normal diploid fibroblasts and induced telomere dysfunction, as evidenced by increased telomere dysfunction-induced foci (TIFs), γH2AX accumulation, G2/M checkpoint arrest, and apoptosis. In orthotopic DIPG xenografts, THIO increased intratumoral TIF formation, suppressed tumor growth, and prolonged survival. Transcriptomic profiling further revealed activation of cellular stress-response pathways and downregulation of E2F genes, mitotic, and metabolism-associated gene programs. Mechanistically, THIO-induced progressive genomic and telomeric damage was associated with sequential activation of ATM and ATR signaling, consistent with engagement of adaptive DDR pathways. Combining THIO with ionizing radiation (IR) produced synergistic antitumor effects across three independent DIPG models representing distinct H3 mutation subtypes, with increased G2/M accumulation, genomic and telomeric DNA damage, and apoptotic cell death. In vivo, THIO combined with IR significantly improved therapeutic efficacy and prolonged median survival compared with monotherapy, including RT alone. Notably, pharmacologic inhibition of ATM or ATR attenuated THIO-induced checkpoint arrest and increased apoptosis, implicating DDR checkpoint signaling as an adaptive survival dependency following telomere damage. Collectively, these findings identify telomere-directed DNA damage as a promising therapeutic approach for DMG and provide a mechanistic rationale for combining THIO with RT and DDR checkpoint inhibition.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-17
DOI
https://doi.org/10.64898/2026.11.13.766496
Primary Topic
Telomeres, Telomerase, and Senescence
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Targeting Telomere Integrity Enhances Radiosensitivity and Reveals Adaptive DNA Damage Response Vulnerabilities in Diffuse Midline Glioma

Sergei M Gryaznov, Shiva Senthil Kumar, Archana Mahadevan Iyer, Rachid Drissi et al.
3 links
bioRxiv (Cold Spring Harbor Laboratory)
Telomeres, Telomerase, and Senescence
preprint

Targeting Telomere Integrity Enhances Radiosensitivity and Reveals Adaptive DNA Damage Response Vulnerabilities in Diffuse Midline Glioma

Sergei M Gryaznov, Shiva Senthil Kumar, Archana Mahadevan Iyer, Rachid Drissi, Hao‐Han Pang, Zhuang Wang, Komal Khan, Banlanjo Umaru, Maryam Foualdi, Deepak K Mishra
preprint en

Abstract

Diffuse midline glioma (DMG), including diffuse intrinsic pontine glioma (DIPG), remains one of the most lethal pediatric malignancies, with limited durable benefit from radiotherapy (RT) due in part to adaptive DNA damage response (DDR) mechanisms. Here, we investigated whether targeting telomere integrity with the telomerase substrate analogue 6-thio-2′-deoxyguanosine (6-thio-dG; THIO) could induce therapeutically exploitable DNA damage in patient-derived DIPG models. THIO selectively suppressed DIPG cell proliferation while sparing telomerase-negative normal diploid fibroblasts and induced telomere dysfunction, as evidenced by increased telomere dysfunction-induced foci (TIFs), γH2AX accumulation, G2/M checkpoint arrest, and apoptosis. In orthotopic DIPG xenografts, THIO increased intratumoral TIF formation, suppressed tumor growth, and prolonged survival. Transcriptomic profiling further revealed activation of cellular stress-response pathways and downregulation of E2F genes, mitotic, and metabolism-associated gene programs. Mechanistically, THIO-induced progressive genomic and telomeric damage was associated with sequential activation of ATM and ATR signaling, consistent with engagement of adaptive DDR pathways. Combining THIO with ionizing radiation (IR) produced synergistic antitumor effects across three independent DIPG models representing distinct H3 mutation subtypes, with increased G2/M accumulation, genomic and telomeric DNA damage, and apoptotic cell death. In vivo, THIO combined with IR significantly improved therapeutic efficacy and prolonged median survival compared with monotherapy, including RT alone. Notably, pharmacologic inhibition of ATM or ATR attenuated THIO-induced checkpoint arrest and increased apoptosis, implicating DDR checkpoint signaling as an adaptive survival dependency following telomere damage. Collectively, these findings identify telomere-directed DNA damage as a promising therapeutic approach for DMG and provide a mechanistic rationale for combining THIO with RT and DDR checkpoint inhibition.

bioRxiv (Cold Spring Harbor Laboratory)
Nationwide Children's Hospital (US), Children's Hospital of Philadelphia (US), Department of Biotechnology (IN), Biotechnology Research Center (IR)
Ohio State University, Cincinnati Children's Hospital Medical Center, Nationwide Children's Hospital, Seattle Children's Research Institute, CancerFree KIDS
Good health and well-being
Telomeres, Telomerase, and Senescence
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon